Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
AssigneeOmeros Corporation
InventorsGregory A. Demopulos, Vincent A. Florio
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for inhibiting postoperative inflammatory conditions following ophthalmologic surgical procedures by administering intraocularly during an ophthalmologic surgical procedure a solution including a nonsteroidal anti-inflammatory agent and an alpha-1 adrenergic mydriatic agent, such as a liquid irrigation solution of ketorolac and phenylephrine.
Claims15
A method for reducing the incidence or severity of a postoperative inflammatory condition following an ophthalmologic surgical procedure in a subject identified as having an elevated risk of suffering from a postoperative inflammatory condition, the method comprising:
- administering to the subject's intraocular tissues during an ophthalmologic surgical procedure an effective amount of a solution including a nonsteroidal anti-inflammatory drug (NSAID) and an alpha-1 adrenergic receptor agonist mydriatic agent in an intraocular irrigation carrier.
Dependencies are inferred from the claim text.